Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling von Marathe, Dhananjay D., Jauslin, Petra M., Kleijn, Huub Jan, de Miranda Silva, Carolina, Chain, Anne, Bateman, Thomas, Shaw, Peter M., Abraham, Anson K., Kauh, Eunkyung A., Liu, Yanfang, Perini, Rodolfo F., de Alwis, Dinesh P., Jain, Lokesh

Volltext

First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors von Siu, Lillian L, Wang, Ding, Hilton, John, Geva, Ravit, Rasco, Drew, Perets, Ruth, Abraham, Anson K, Wilson, Douglas C, Markensohn, Julia F, Lunceford, Jared, Suttner, Leah, Siddiqi, Shabana, Altura, Rachel A, Maurice-Dror, Corinne

Volltext

Pivotal Dose of Pembrolizumab: A Dose‐Finding Strategy for Immuno‐Oncology von Li, Tommy R., Chatterjee, Manash, Lala, Mallika, Abraham, Anson K., Freshwater, Tomoko, Jain, Lokesh, Sinha, Vikram, Alwis, Dinesh P., Mayawala, Kapil

Volltext

Exposure–Response Analyses for Belzutifan to Inform Dosing Considerations and Labeling von Marathe, Dhananjay D., Jauslin, Petra M., Jan Kleijn, Huub, De Miranda Silva, Carolina, Chain, Anne, Abraham, Anson K., Kauh, Eunkyung A., Liu, Yanfang, Perini, Rodolfo F., Alwis, Dinesh P. de, Jain, Lokesh

Volltext

Correction: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors von Siu, Lillian L, Wang, Ding, Hilton, John, Geva, Ravit, Rasco, Drew, Perets, Ruth, Abraham, Anson K, Wilson, Douglas C, Markensohn, Julia F, Lunceford, Jared, Suttner, Leah, Siddiqi, Shabana, Altura, Rachel A, Maurice-Dror, Corinne

Volltext

Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Parathyroid Hormone-Calcium Homeostasis in Rats and Humans von Abraham, Anson K, Mager, Donald E, Gao, Xiang, Li, Mei, Healy, David R, Maurer, Tristan S

Volltext

Correction: First-in-Class Anti-Immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors von Siu, Lillian L, Wang, Ding, Hilton, John, Geva, Ravit, Rasco, Drew, Perets, Ruth, Abraham, Anson K, Wilson, Douglas C, Markensohn, Julia F, Lunceford, Jared, Suttner, Leah, Siddiqi, Shabana, Altura, Rachel A, Maurice-Dror, Corinne

Volltext

Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling von Tiwari, Abhinav, Abraham, Anson K., Harrold, John M., Zutshi, Anup, Singh, Pratap

Volltext

Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I Interferons von Kagan, Leonid, Abraham, Anson K, Harrold, John M, Mager, Donald E

Volltext

Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature von Visintin, Alberto, Knowlton, Kelly, Tyminski, Edyta, Lin, Chi-Iou, Zheng, Xiang, Marquette, Kimberly, Jain, Sadhana, Tchistiakova, Lioudmila, Li, Dan, O'Donnell, Christopher J, Maderna, Andreas, Cao, Xianjun, Dunn, Robert, Snyder, William B, Abraham, Anson K, Leal, Mauricio, Shetty, Shoba, Barry, Anthony, Zawel, Leigh, Coyle, Anthony J, Dvorak, Harold F, Jaminet, Shou-Ching

Volltext

Erratum to: Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling von Tiwari, Abhinav, Abraham, Anson K., Harrold, John M., Zutshi, Anup, Singh, Pratap

Volltext

Simulations of site-specific target-mediated pharmacokinetic models for guiding the development of bispecific antibodies von Chudasama, Vaishali L., Zutshi, Anup, Singh, Pratap, Abraham, Anson K., Mager, Donald E., Harrold, John M.

Volltext

Mechanisms of interferon-β effects on bone homeostasis von Abraham, Anson K., Ramanathan, Murali, Weinstock-Guttman, Bianca, Mager, Donald E.

Volltext

Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment von Harrold, John M., Abraham, Anson K.

Volltext

Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in mice von Abraham, Anson K, Kagan, Leonid, Kumar, Sarmishtha, Mager, Donald E

Volltext

Partial derivative-based sensitivity analysis of models describing target-mediated drug disposition von Abraham, Anson K, Krzyzanski, Wojciech, Mager, Donald E

Volltext

Pharmacodynamic Model of Parathyroid Hormone Modulation by a Negative Allosteric Modulator of the Calcium-Sensing Receptor von Abraham, Anson K., Maurer, Tristan S., Kalgutkar, Amit S., Gao, Xiang, Li, Mei, Healy, David R., Petersen, Donna N., Griffith, David A., Mager, Donald E.

Volltext

Mechanisms of interferon-[beta] effects on bone homeostasis von Abraham, Anson K, Ramanathan, Murali, Weinstock-Guttman, Bianca, Mager, Donald E

Volltext

DOSING REGIMENS OF ANTI-ILT4 ANTIBODY OR ITS COMBINATION WITH ANTI-PD-1 ANTIBODY FOR TREATING CANCER von Abraham, Anson K, Wilson, Douglas C, Altura, Rachel A

Volltext bestellen

METHODS FOR TREATING HEMATOLOGIC MALIGNANCIES WITH AMINO-PYRROLOPYRIMIDINONE COMPOUNDS von MARINELLO, Patricia, MAYAWALA, Kapil, ABRAHAM, Anson K, FAROOQUI, Mohammed Z. H

Volltext bestellen